BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

China’s DualityBio Secures FDA Fast Track for Next-Gen HER3 ADC DB-1310 in Advanced Lung Cancer

DualityBio announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting a...

July 23, 2025 | News

10x Genomics and A*STAR GIS Join Forces to Advance Precision Medicine Through AI-Powered Spatial Biology

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), announced a resea...

July 21, 2025 | News

Hyphens Pharma Launches Winlevi® in Singapore and Malaysia, Ushering in a New Era of Acne Treatment in Southeast Asia

Hyphens Pharma Pte. Ltd., a subsidiary of SGX Catalist-listed Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...

July 18, 2025 | News

GC Biopharma Secures Vietnam Approval for Antibiotic-Free Varicella Vaccine BARYCELA

GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from th...

July 18, 2025 | News

SK bioscience Pioneers Korea’s First Adjuvanted Flu Vaccine with IND Filing for NBP607B

Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2...

July 18, 2025 | News

Senhwa Biosciences’ CX-5461 Selected by U.S. National Cancer Institute for Major Oncology Research Programme

Senhwa Biosciences, Inc., a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, ...

July 17, 2025 | News

GHIT Fund Commits JPY 1 Billion to Combat Malaria and Tuberculosis Through Global R&D Partnerships

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in ...

July 17, 2025 | News

Akeso Begins Phase III Trial of Ivonescimab for Hard-to-Treat Advanced Colorectal Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration Phas...

July 16, 2025 | News

DKSH Partners with Bayer to Expand Access to Cardiovascular and Women’s Health Products Across Southeast Asia

DKSH has signed a strategic business partnership with life science company Bayer, to provide comprehensive services for a portion of t...

July 10, 2025 | News

Quanterix Completes Acquisition of Akoya Biosciences, Expanding Leadership in Multi-Tissue Biomarker Detection

Quanterix Corporation, a company fueling scientific discovery through ultra-sensitive biomarker detection, announced that it has completed its previously a...

July 09, 2025 | News

Bio-Rad Launches Four New ddPCR Platforms Following Stilla Technologies Acquisition

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of four ...

July 09, 2025 | News

Sirtex Secures FDA Approval for SIR-Spheres® Y-90 in Treating Unresectable Hepatocellular Carcinoma

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food and Drug Administration (F...

July 08, 2025 | News

Celltrion Launches STOBOCLO® and OSENVELT® Biosimilars in the U.S. for Comprehensive Bone Health and Oncology Care

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and X...

July 08, 2025 | News

ImmunityBio Secures First International Approval for ANKTIVA® in the UK for Bladder Cancer Treatment

ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, he...

July 08, 2025 | News

Stay Connected